FDA issues warning on use of azithromycin

03/13/2013 | Los Angeles Times (tiered subscription model) · Reuters

The FDA issued a warning that the antibiotic azithromycin, marketed as Zithromax or Zmax, could cause potentially fatal irregular heart rhythm in some patients. The agency said at-risk patients include those with a slower-than-normal heartbeat, with potassium or magnesium deficiencies, and those using medications to treat existing heart arrhythmia.

View Full Article in:

Los Angeles Times (tiered subscription model) · Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR